The National Institute on Drug Abuse (NIDA), Station Support and Simplified Acquisitions Branch (SS/SA) intends to negotiate and award a purchase order without providing for full and open competition (Including brand-name) to Qiagen, Inc. for one (1) QiaCube Tissue Lyser LT System.

NORTH AMERICAN INDUSTRY CLASSIFICATION SYSTEM (NAICS) CODE
The intended procurement is classified under NAICS code 334516 with a Size Standard of 500 employees.

REGULATORY AUTHORITY
The resultant contract will include all applicable provisions and clauses in effect through the Federal Acquisition Circular (FAC) 05- 69 dated August 1, 2013.

This acquisition is conducted under the procedures as prescribed in FAR subpart 13-Simplified Acquisition Procedures at an amount not exceeding the simplified acquisition threshold ($150,000).

STATUTORY AUTHORITY
This acquisition is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13-Simplified Acquisition Procedures, Subpart 13.106-1 (b) (1), Soliciting from a single source and is not expected to exceed the simplified acquisition threshold. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements.

DESCRIPTION OF REQUIREMENT

Background - The National Institute of Mental Health (NIMH) Human Brain Collection Core (HBCC) researches extracted RNA and DNA and requires automation and increased throughput capabilities. The HBCC has been using Qiagen purification kits for this work since 2008 and requires a system that will provide comparable, standardized data.

Purpose and Objectives
The purpose of this requirement is acquisition of one (1) Qiagen QiaCube Tissue Lyser LT for brain tissue sample preparation.

Period of Performance
Delivery and installation of the abovementioned products is expected to be concluded within eight (8) weeks of a contract award. A firm fixed price award is anticipated.

Project Description
Qiagen, Inc. will provide one (1) QiaCube Tissue Lyser LT System which will include the following products:

Manufacturer's Part Number                          Product
9001883                                      QIAcube (110V), priority package
85600                                          TissueLyser LT
69980                                          TissueLyser LT Adapter, 12-Tube
69965                                          TissueLyser Single-Bead Dispenser, 5mm
69989                                          Stainless Steel Beads, 5mm (200)

CONTRACTING WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME) DETERMINATION
The determination by the Government to award a contract without providing for full and open competition is based upon the market research conducted. The intended source is:

Qiagen, Inc.
27220 Turnberry Ln
Valencia, CA, 91355-1018

Qiagen, Inc. is the sole manufacturer of the required QiaCube Tissue Lyser LT and a sources sought notice posted to FedBizOpps.gov resulted in the identification of no small business resellers able to meet the requirement. It is imperative that the QiaCube Tissue Lyser LT be purchased to meet the automation and throughtput requirements of the HBCC while also maintain compatible, standardized data as compared to research already performed.

CLOSING STATEMENT
This synopsis is not a request for competitive proposals. However, interested parties may identify their interest and capability to respond to this notice. Responses to this notice shall contain sufficient information to establish the interested parties' bona-fide capabilities for fulfilling the requirement and include: unit price, list price, shipping and handling costs, the delivery period after contract award, the prompt payment discount terms, the F.O.B. Point (Destination or Origin), the Dun & Bradstreet Number (DUNS), the Taxpayer Identification Number (TIN), and the certification of business size. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov."

A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. The information received will normally be considered solely for the purposes of determining whether to proceed on a non-competitive basis or to conduct a competitive procurement.

All responses must be received by August 28, 2013 at 12:00 PM EST and must reference number HHS-NIH-NIDA-PS- 2013-3033438. Responses may be submitted electronically to Lauren Phelps at [email protected] or by U.S. mail to the National Institute on Drug Abuse (NIDA), Station Support Contracts and Simplified Acquisitions Branch (SS/SA) 31 Center Drive, Room 1B59, Bethesda, Maryland 20892, Attention: Lauren Phelps. Fax responses will not be accepted.

"All responsible sources may submit a capability statement, proposal, or quotation, which shall be considered by the agency."